Skip to main content
Clinical Trials/JPRN-UMIN000011242
JPRN-UMIN000011242Completed未知

Efficacy and safety of tocilizumab monotherapy in patients with microscopic polyangiitis - Tocilizumab mono-therapy for microscopic polyangiitis

Saitama Medical Center, Saitama Medical University Department of Rheumatology and Clinical Immunology0 sites10 target enrollmentStarted: September 1, 2013Last updated:
Conditions

Trial Snapshot

Phase
未知
Status
Completed
Sponsor
Enrollment
10

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
20years-old to 80years-old (—)
Sex
All

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1) patients who are prohibited to use tocilizumab by the JCR guideline for proper tocilizumab use 2) patients who are thought to be inappropriate for the treatment with tocilizumab by their attending doctor

Investigators

Sponsor
Saitama Medical Center, Saitama Medical University Department of Rheumatology and Clinical Immunology

Similar Trials